Transforming growth factor beta 1 increases IgA isotype switching at the clonal level

Area of Science:

• Immunology
• Molecular Biology

Background:

• Transforming growth factor beta 1 (TGF beta 1) influences immunoglobulin A (IgA) isotype expression.
• TGF beta 1, with IL-5 or IL-2, enhances IgA secretion from LPS-activated sIgA- spleen B cells, while reducing IgM and IgG.
• The role of TGF beta 1 as an IgA isotype switch factor requires clarification at the clonal level.

Purpose of the Study:

• To investigate the activity of TGF beta 1 as an IgA isotype switch factor at the clonal level.
• To determine the effect of TGF beta 1 and IL-2 on IgA-secreting B cell populations and secretion.
• To explore the potential mechanisms underlying TGF beta 1's IgA-enhancing activity.

Main Methods:

• Limiting dilution analysis of LPS-activated sIgA- spleen B cells.
• Stimulation with TGF beta 1, IL-2, or combinations thereof.
• Assessment of IgA, IgM, and IgG secretion.
• Evaluation of cell cycle inhibitors (thymidine, hydroxyurea).

Main Results:

• TGF beta 1 significantly increased the total number and secretion of IgA-producing cells.
• TGF beta 1 elevated the frequency of IgA-secreting B cell clones approximately 20-fold.
• IL-2 enhanced IgA production in committed B cells but was not an IgA switch factor itself.
• Cell cycle inhibitors also increased IgA secretion, suggesting a role for growth inhibition.

Conclusions:

• TGF beta 1 acts as a potent IgA isotype switch factor at the clonal level.
• The IgA-enhancing effect of TGF beta 1 may be partly mediated by its ability to inhibit B cell growth.
• IL-2 supports IgA production but does not induce isotype switching to IgA.